Active ingredientEthosuximideCat. No. P-E122-001CAS 77-67-8Family · Pharmaceutical analytical standards
Ethosuximide
An antiepileptic of the succinimide family, approved in the United States in 1960: it acts on T-type calcium channels in the thalamus and is considered a first-choice medicine for absence seizures. This family brings together the active ingredient, pharmacopoeial impurities and labelled standards.
Did you know?Its family name comes from succinic acid, from the Latin succinum, amber: it was once obtained by distilling amber and was known as "spirit of amber".
Go to the active ingredient →Active ingredientEthosuximideCat. No. P-E122-001CAS 77-67-8
Pharmacopoeial impurityEthosuximide EP Impurity ACat. No. P-E122-002CAS 631-31-2
Isotopically labelledEthosuximide-d3Cat. No. P-E122-003CAS 1189703-33-0
Isotopically labelledEthosuximide-d5Cat. No. P-E122-004CAS 1989660-59-4No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Reference substanceEthosuximide CRSEDQM code E2150000Family EthosuximideImpurityEthosuximide impurity A CRSEDQM code E2250000Family EthosuximideNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.